Bumper Offer - Urjas oil Just @ Rs. 1
Clopitab CV 10 Capsule (15) is a prescription drug, available for use as Capsule. Secondary and off-label uses of Clopitab CV 10 Capsule (15) have also been mentioned below.
The correct dosage of Clopitab CV 10 Capsule (15) depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Clopitab CV 10 Capsule (15) also has some side effects, the most common being Headache, Nasopharyngitis, Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Clopitab CV 10 Capsule (15) as well, which are listed below. Such side effects of Clopitab CV 10 Capsule (15) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Clopitab CV 10 Capsule (15)'s effect during pregnancy is Moderate and Mild while nursing. It is important to know if Clopitab CV 10 Capsule (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Clopitab CV 10 Capsule (15) related warnings section.
Individuals suffering from medical conditions like Liver Disease, Alcoholism, Bleeding must refrain from the use of Clopitab CV 10 Capsule (15) since this can cause severe adverse effects. Other conditions have been mentioned below in the Clopitab CV 10 Capsule (15) contraindications section.
Drug reaction of Clopitab CV 10 Capsule (15) with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Clopitab CV 10 Capsule (15), it is important to know that it is safe while driving, and is habit-forming.
Clopitab CV 10 Capsule (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Clopitab CV 10 Capsule (15) safe for pregnant women?
Clopitab Cv can have harmful effects in pregnant women. If you experience any discomfort after using Clopitab Cv, then discontinue the use and take your doctor's advice.
Is the use of Clopitab CV 10 Capsule (15) safe during breastfeeding?
Clopitab Cv may have very limited harmful effects for breastfeeding women.
What is the effect of Clopitab CV 10 Capsule (15) on the Kidneys?
Clopitab Cv rarely harms the kidneys.
What is the effect of Clopitab CV 10 Capsule (15) on the Liver?
You may experience side effects on your liver after taking Clopitab Cv. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Clopitab CV 10 Capsule (15) on the Heart?
Clopitab Cv has very mild side effects on the heart.
Clopitab CV 10 Capsule (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Clopitab CV 10 Capsule (15) unless your doctor advises you to do so -
Is this Clopitab CV 10 Capsule (15) habit forming or addictive?
Clopitab CV 10 Capsule (15) is not addictive in nature.
Interaction between Food and Clopitab CV 10 Capsule (15)
Eating certain foods may increase the time it takes Clopitab CV 10 Capsule (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Clopitab CV 10 Capsule (15)
Information about the interaction of Clopitab CV 10 Capsule (15) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
